Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

An exploration of clinical interventions provided by pharmacists within a complex asthma service.

Lemay KS, Saini B, Bosnic-Anticevich S, Smith L, Stewart K, Emmerton L, Burton DL, Krass I, Armour CL.

Pharm Pract (Granada). 2015 Jan-Mar;13(1):529. Epub 2015 Mar 15.

2.

Hypertension in Older Persons: A Systematic Review of National and International Treatment Guidelines.

Alhawassi TM, Krass I, Pont LG.

J Clin Hypertens (Greenwich). 2015 Mar 31. doi: 10.1111/jch.12536. [Epub ahead of print]

PMID:
25827023
3.

Factors influencing the provision of adherence support by community pharmacists: A structural equation modeling approach.

Mansoor SM, Krass I, Costa DS, Aslani P.

Res Social Adm Pharm. 2015 Feb 3. pii: S1551-7411(15)00031-5. doi: 10.1016/j.sapharm.2015.01.004. [Epub ahead of print]

PMID:
25749550
4.

Investigating general practitioner engagement with pharmacists in home medicines review.

Costa D, Van C, Abbott P, Krass I.

J Interprof Care. 2015 Feb 18:1-7. [Epub ahead of print]

PMID:
25692718
5.

The reliability and utility of spirometry performed on people with asthma in community pharmacies.

Burton DL, LeMay KS, Saini B, Smith L, Bosnic-Anticevich S, Southwell P, Cooke J, Emmerton L, Stewart K, Krass I, Armour C.

J Asthma. 2015 Jan 7:1-27. [Epub ahead of print]

PMID:
25563059
6.

A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting.

Alhawassi TM, Krass I, Bajorek BV, Pont LG.

Clin Interv Aging. 2014 Dec 1;9:2079-86. doi: 10.2147/CIA.S71178. eCollection 2014.

7.

Adherence to diabetes medication: a systematic review.

Krass I, Schieback P, Dhippayom T.

Diabet Med. 2014 Nov 29. doi: 10.1111/dme.12651. [Epub ahead of print]

PMID:
25440507
8.

Challenges in the care of clients with established cardiovascular disease: lessons learned from Australian community pharmacists.

Puspitasari HP, Aslani P, Krass I.

PLoS One. 2014 Nov 19;9(11):e113337. doi: 10.1371/journal.pone.0113337. eCollection 2014.

9.

Nationwide collaborative development of learning outcomes and exemplar standards for Australian pharmacy programmes.

Stupans I, McAllister S, Clifford R, Hughes J, Krass I, March G, Owen S, Woulfe J.

Int J Pharm Pract. 2014 Nov 13. doi: 10.1111/ijpp.12163. [Epub ahead of print]

PMID:
25395348
10.

Medication-taking behaviour in New South Wales patients with type 2 diabetes: an observational study.

Dhippayom T, Krass I.

Aust J Prim Health. 2014 Sep 3. doi: 10.1071/PY14062. [Epub ahead of print] No abstract available.

PMID:
25183196
11.

A pharmacy asthma service achieves a change in patient responses from increased awareness to taking responsibility for their asthma.

Naik-Panvelkar P, Saini B, LeMay KS, Emmerton LM, Stewart K, Burton DL, Bosnic-Anticevich SZ, Krass I, Smith LD, Armour CL.

Int J Pharm Pract. 2015 Jun;23(3):182-91. doi: 10.1111/ijpp.12134. Epub 2014 Jul 4.

PMID:
24995681
12.

A comparison of screening methods for sleep disorders in Australian community pharmacies: a randomized controlled trial.

Fuller JM, Wong KK, Grunstein R, Krass I, Patel J, Saini B.

PLoS One. 2014 Jun 30;9(6):e101003. doi: 10.1371/journal.pone.0101003. eCollection 2014.

13.

Development and validation of the Attitudes to Pharmacist Services for Diabetes Scale (APSDS).

Krass I, Costa D, Dhippayom T.

Res Social Adm Pharm. 2015 Jan-Feb;11(1):74-84. doi: 10.1016/j.sapharm.2014.04.005. Epub 2014 May 6.

PMID:
24874176
14.

Medication Safety: an audit of medication discrepancies in transferring type 2 diabetes mellitus (T2DM) patients from Australian primary care to tertiary ambulatory care.

Azzi M, Constantino M, Pont L, Mcgill M, Twigg S, Krass I.

Int J Qual Health Care. 2014 Aug;26(4):397-403. doi: 10.1093/intqhc/mzu051. Epub 2014 May 19.

PMID:
24840003
15.
16.

Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.

Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J, Bennett AA, Briffa T, Bauman A, Martinez C, Wallenhorst C, Lau JK, Brieger DB, Sy RW, Freedman SB.

Thromb Haemost. 2014 Jun;111(6):1167-76. doi: 10.1160/TH14-03-0231. Epub 2014 Apr 1.

PMID:
24687081
17.

Use of medications for secondary prevention in stroke patients at hospital discharge in Australia.

Eissa A, Krass I, Bajorek BV.

Int J Clin Pharm. 2014 Apr;36(2):384-93. doi: 10.1007/s11096-013-9908-3. Epub 2014 Feb 12.

PMID:
24519632
18.
19.

How diabetes risk assessment tools are implemented in practice: a systematic review.

Dhippayom T, Chaiyakunapruk N, Krass I.

Diabetes Res Clin Pract. 2014 Jun;104(3):329-42. doi: 10.1016/j.diabres.2014.01.008. Epub 2014 Jan 15. Review.

PMID:
24485859
20.

Australian community pharmacists' awareness and practice in supporting secondary prevention of cardiovascular disease.

Puspitasari HP, Aslani P, Krass I.

Int J Clin Pharm. 2013 Dec;35(6):1218-28. doi: 10.1007/s11096-013-9854-0. Epub 2013 Sep 21.

PMID:
24057435
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk